Expression of Drug Targets in Patients Treated with Sorafenib, Carboplatin and Paclitaxel
Lucia B. Jilaveanu(Yale University), Harriet M. Kluger(Yale Cancer Center)
Cited by 3
Related Papers
Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma
|Clinical Cancer Research|2009|72
Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens
|Oncotarget|2015|64
Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
|Journal of Translational Medicine|2011|51
Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases
|Journal of Neuro-Oncology|2020|27